Elizabeth O’Farrell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Elizabeth O’Farrell
Earlier roles on record: Board Member at Inhibikase Therapeutics, Inc. (IKT) until September 1, 2022. Inhibikase Therapeutics, Inc. reported in an 8-K filed September 1, 2022 that Elizabeth O’Farrell retired as Board, effective September 1, 2022.
“On September 1, 2022, Elizabeth O'Farrell provided notice to the Board of Directors (the "Board") of Inhibikase Therapeutics, Inc. (the "Company") of her intention to retire from the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-09-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.